Author:
Spencer Barbara E.,Irwin David J.,Van Deerlin Vivianna M.,Suh EunRan,Lee Edward B.,Elman Lauren B.,Quinn Colin C.,Amado Defne,Baer Michael,Grossman Murray,Wolk David A.,McMillan Corey T.
Abstract
AbstractThe contribution of genotypes to the shared and disparate clinical and pathologic features observed across TDP-43 proteinopathies is unclear. TDP-43 pathology can contribute to very different neurodegenerative conditions, including frontotemporal lobar degeneration with TDP-43 (FTLD-TDP), amyotrophic lateral sclerosis (ALS), and hippocampal sclerosis of aging (HS-Aging). Despite mounting evidence for shared genetic risk across these TDP-43 proteinopathies, the drivers of individual-level presentations of these syndromes are unknown. We identified data-driven modules of correlated single nucleotide polymorphisms using GWAS summary statistics. These genomic features were either phenotype specific or shared across TDP-43 proteinopathy phenotypes and may contribute to phenotypic heterogeneity in these cases. Pathway analysis revealed biologically meaningful associations within the identified modules, including common nervous system processes and distinct, phenotype-specific associations. We derived module-specific polygenic scores and hypothesized that they would contribute to individual-level differences in the clinical presentation and corresponding anatomic distribution of pathology. Within characteristic FTLD-TDP brain regions, higher FTLD-TDP polygenic risk associated with higher TDP-43 burden. Further, module-specific ALS and FTLD-TDP polygenic risk associated with clinical phenotypic heterogeneity, even within the context of autosomal dominant mutation carriers. We suggest that genotypic variation across TDP-43 proteinopathies may contribute to individual-level presentations of these syndromes.
Publisher
Cold Spring Harbor Laboratory